**87/100. One unresolved HIGH; no CRITICAL issues.** The patient reconciliation and primary-point reproduction pass. C1, C6 and C7 remain PARTIAL. This score grants no gate.

Paths below are relative to `cancer-dependency-rsi/`.

1. **HIGH — Atlas repair PARTIAL: CDK6’s significance qualifications remain incorrect.**  
   [src/build_atlas_v4.py:26](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/build_atlas_v4.py:26) combines the findings into `MWU/CN-correlation q<0.005 screen`. However, [S1’s cached text:4](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/papers/PMC13581591.xml:4) reports glial-versus-mesenchymal enrichment of Δdependency = −0.44, **P=0.013 but q=0.28**, explicitly below the multiple-testing significance threshold. CDKN2A copy-number correlations have separate qualifications: across GBM, r=0.520/q=4.12×10⁻⁵; within glial GBM, r=0.640/q=0.0340. The drug-response P values are correctly transcribed.

   WNT consistency, tested-not-significant wording and legacy-field reconciliation are repaired. The direct atlas regression test passes, but [tests/test_atlas_v4.py:15](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/tests/test_atlas_v4.py:15) checks presence rather than these qualifications.

   **Exact fix:** replace the combined threshold with separate dependency, copy-number and drug-response statements, explicitly retaining q=0.28 as nonsignificant. Regenerate v4 and its hashes; add assertions for these distinct qualifications.

2. **HIGH — Prospective-lock issue RESOLVED through honest downgrade.**  
   [pgen001/DISPOSITION_v2.json:3](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/pgen001/DISPOSITION_v2.json:3) records FAILS-SCREEN/exploratory protocol deviation and expressly rejects backdating. [ledger/experiments.jsonl:33](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/ledger/experiments.jsonl:33), `:36` and `:39` contain the pgen002, pgen003 and sgen001 locks before their recorded generation results. All three current SPEC hashes and both amendment hashes match.

   **Exact fix:** no further substantive lock repair required. Correct the surviving index assertion identified under issue 8.

3. **MEDIUM — Screen-bar repair PARTIAL: declaration exists, but two PASS labels remain unsupported.**  
   Pgen002 correctly retains an overall PENDING verdict and names the incomplete C mapping. Its license document and retained hash check out. However, [screen_verdict_v1.json:6](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/pgen002/screen_verdict_v1.json:6) still calls token accounting PASS under a “conservative” rule that the endpoint reviewer explicitly rejected.

   I reproduce **14,566,608 charged TOK = 10,456,357 measured + 4,110,251 imputed**. Arithmetic agreement does not establish conservatism. Also, [SPEC.md:13](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/pgen002/SPEC.md:13) requires size **and MD5**; the receipt supplies a multipart ETag, not an MD5 checksum. Criterion 2’s PASS therefore exceeds its frozen evidence.

   **Exact fix:** append a versioned disposition removing these PASS claims and incorporating the endpoint NO ruling. Identify the missing valid failure accounting and checksum witnesses. Preserve the frozen SPEC; any redesigned endpoint needs a new ledger-first SPEC. Implement and witness CPU measurement before asserting it.

4. **MEDIUM — Receipt repair PARTIAL: acquisition is substantially more auditable, but “metadata-only download” is contradicted by the ranges.**  
   [probe_results_v2.json:149](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/pgen002/probe_results_v2.json:149) records a tail beginning at byte **2,847,740,269**, while `:165` places the central directory at **2,847,832,321**. Thus **92,052 bytes preceding the directory** were fetched. This occurred in both pgen002 probes. Pgen003’s [archive_listing.json:5](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/pgen003/archive_listing.json:5) similarly fetched **259,837 bytes before its central directory**.

   These are compressed member-payload overfetches. They do **not** establish that outcome values were decoded, but they defeat categorical metadata-only acquisition claims. Pgen002’s two retained probes total **10 requests/2,009,748 bytes**, within the numerical ceilings. The Passports CSV’s manifest hash and byte count match.

   Pgen001’s disposition marks historical counts unverified, yet [DISPOSITION_v2.json:10](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/pgen001/DISPOSITION_v2.json:10) still categorically asserts no outcome access despite missing historical receipts.

   **Exact fix:** append an acquisition-deviation record distinguishing compressed payload transfer from decoded-value exposure; correct affected claims and cumulative accounting. Qualify unsupported pgen001 non-exposure assertions. Future probes should use fail-closed EOCD/directory ranges, validate `206`/`Content-Range`, enforce byte caps before reading, and retain directory bytes and acquisition-code hashes.

5. **MEDIUM — Novelty-search repair PARTIAL: outstanding work is disclosed, but the backward check overstates coverage.**  
   [adjudication_dossier_v1.md:20](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen001/adjudication_dossier_v1.md:20) describes complete reference lists of 72/96/38 entries. The cached XML bibliographies contain **76/103/41** references. Europe PMC’s returned subset omits, among others, **S3’s reference 41, its Zenodo reproducibility package**, directly relevant to the requested closest-code check.

   The narrow `format|medium|minipool` title screen also misses a relevant retained title: [backward_references.json:109](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen001/backward_references.json:109), PMID 32238925, *CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities*. Its title does not establish anticipation, but it requires a substantive disposition. The retained v5 searches contain S1/S3 forward checks, **no S2 forward-citation check**.

   **Exact fix:** reconcile API lists against cached bibliographies; describe API coverage accurately; screen relevant abstracts/methods and the closest code package; retain record-specific dispositions. Complete or explicitly name S2 forward screening and remaining supplement checks. Keep novelty qualification conditional meanwhile.

6. **MEDIUM — Reopening-scope issue RESOLVED.**  
   [pgen001/DISPOSITION_v2.json:8](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/pgen001/DISPOSITION_v2.json:8) limits failure to the tested specification. [discriminator_v2.json:5](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/reviews/cl_rd_raw_accounting_discriminator_v2.json:5) preserves both measured-expenditure and justified alternative-endpoint routes, with material-resource requirements.

   **Exact fix:** none further; retain these conditions in subsequent specifications.

7. **LOW — S3 section-reference issue RESOLVED.**  
   [novelty_audit_v5.md:7](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/reviews/novelty_audit_v5.md:7) correctly identifies **§2.10.1/§3.7 and Tables S17–S19**. These sections and the quoted ranking summaries agree with [PMC13664187.xml:1](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/data/papers/PMC13664187.xml:1). Section 3.5 concerns cross-cohort target-wise synthesis.

   **Exact fix:** none further; the supersession of v4’s references is explicit.

8. **LOW — Live-status repair PARTIAL; it is already stale again.**  
   The checkpoint now records the external execution and atlas v4. However, [status.json:22](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/status.json:22) still calls endpoint adjudication running/unadjudicated; `:104` and [STATUS.md:129](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/STATUS.md:129) still direct immediate progression toward a pgen004 battery. Neither reflects ENDPOINT:NO/PGEN004:NO_GO or sgen001’s completed dossier. [GENERATIONS.md:4](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/GENERATIONS.md:4) retains the false pre-probe-lock assertion without an explicit pgen001 correction.

   **Exact fix:** update live status and append a checkpoint accepting the endpoint ruling, naming its reopening witnesses, recording sgen001’s review disposition, and placing sgen002 reproduction next. Append an explicit correction superseding the pgen001 index claim. Replace the manuscript’s “established a measured-token accounting route” description with the rejected-as-written disposition.

**Endpoint ruling and ranked execution:** I uphold ENDPOINT:NO and PGEN004:NO_GO. [The ruling:9](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/reviews/pgen004_design_xhigh_v1.md:9) correctly distinguishes measured tokens from known/matched host expenditure and rejects maximum-completed-call imputation as a failure bound. Observed execution follows the first ranked scientific generation: sgen001 was locked after the consultation returned. The point reproduction is an admissible component of the second recommendation, not a complete sgen002 reproduction. I found **no executed endpoint switch or post-ruling policy run**. Formal acceptance is incompletely propagated into the live artifacts; issue 8 specifies the repair.

**Pgen003 verdict: upheld.** Independent reconstruction from the requested three sources gives:

| Quantity | Recomputed |
|---|---:|
| Count files / filename line keys | 1,122 / 360 |
| Matched lines / patients | 252 / 251 |
| C models mapped / patients | 148 / 142 |
| C-overlap patients | 0 |
| Broad-exposed line | KP3 |
| Eligible lines / patients / files | **251 / 250 / 810** |

Every `matched_detail` record agrees with `eligibility_recompute_v1.json`. Witness B remains **252<330**, so [FAILS-SCREEN:3](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/pgen003/screen_verdict_v1.json:3) is faithful. Designing a new resolved-universe specification does not retroactively pass this screen.

9. **MEDIUM — NEW: identity is confirmed, but the inferential caveat is incomplete.**  
   The clinical worksheet reproduces the recorded individual IDs, stages and ages. The manifested Passports CSV independently corroborates the receipted patient records:

   - **SIDP01937:** COLIVM_031/061, ages 69/70; explicit reciprocal same-patient comments.
   - **SIDP01939:** COLIVM_051, COLIVM_090 and COLO_478, ages 74/76/74; common patient grouping and sample membership. The comment explicitly links COLO_478/051; 090’s linkage comes from patient membership.

   Therefore **148 models/142 patients is CONFIRMED**. This does not establish a general attendance-level definition for S2’s `individual_ID`; it establishes that these IDs fail to uniquely identify patients in the affected records.

   I **refute “slightly” as an established qualification** in [manuscript_draft_v1.md:28](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/manuscript/manuscript_draft_v1.md:28). The effect’s size and direction are unknown. Moreover, [confirmatory_estimand.py:16](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/confirmatory_estimand.py:16) averages within donor IDs before equal-group aggregation at `:58`. Correcting identities can therefore change **point-estimate weights as well as bootstrap dependence**.

   **Exact fix:** state that the archived estimate and BOUND decision used 144 covariate-ID groups; two actual patients were split across groups; effects on the patient-weighted estimate, interval and decision are unquantified. Remove “slightly,” avoid presenting the archived interval as validated patient-cluster uncertainty, and propagate this qualification to current result summaries. Preserve the original execution; any permitted regrouping is exploratory sensitivity.

**Component reproduction: PASS.** Independently ranking `D_g`, `L_g` and `base_strength`, residualizing against ranked baseline strength, and correlating residuals yields **−0.1458320500587953** across 207 unique coordinates. Difference from the frozen estimate: **2.7755575615628914×10⁻¹⁷**, agreeing with [repro_primary_point_v1.json:3](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/reviews/repro_primary_point_v1.json:3) and satisfying the requested tolerances. This reproduces the archived point, not corrected patient weighting, donor intervals or full C11.

Against handoff §12: **C1 PARTIAL** because the precise residual question is well distinguished from S1–S3, but relevant citation/code checks remain incomplete. **C6 PARTIAL** because the candidate addresses a meaningful predeclared uncertainty, while novelty qualification and patient-level inferential support remain unresolved. **C7 PARTIAL** because coverage is complete—250 genes, 43 exclusions, 3,000 paired observations—but CDK6’s prior-evidence qualification remains materially wrong.

No files were modified; no network requests or new dependency-outcome decoding were performed.

V3_SGEN001_REVIEW_SCORE: 87; C1:PARTIAL; C6:PARTIAL; C7:PARTIAL; IDENTITY:CONFIRMED